Jeffrey D. Blume, Ph.D.
Affiliations: | 2000 | Johns Hopkins University, Baltimore, MD |
Area:
StatisticsGoogle:
"Jeffrey Blume"Parents
Sign in to add mentor| Richard Royall | grad student | 2000 | Johns Hopkins | |
| (On the probability of observing misleading evidence in sequential trials.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Virostko J, Hainline A, Kang H, et al. (2018) Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis. Journal of Medical Imaging (Bellingham, Wash.). 5: 011011 |
| Hylton NM, Blume JD, Bernreuter WK, et al. (2012) Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology. 263: 663-72 |
| Berg WA, Blume JD, Adams AM, et al. (2010) Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology. 254: 79-87 |
| Hylton N, Blume J, Gatsonis C, et al. (2009) MRI tumor volume for predicting response to neoadjuvant chemotherapy in locally advanced breast cancer: Findings from ACRIN 6657/CALGB 150007. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 529 |
| Blume J, Piantadosi S, Royall R. (1996) A61 Likelihood analysis of sequential trials Controlled Clinical Trials. 17: S73 |